Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].

Okamura T, Kawachi Y, Nikkuni K, Nishimura A, Makino S, Kawahara M, Kitami C, Hashimoto Y.

Gan To Kagaku Ryoho. 2013 May;40(5):671-3. Japanese.

PMID:
23863598
2.

[A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].

Toyokawa A, Nakajima T, Inui K, Yamashita H, Gon H, Kanemitsu K, Tanaka K, Tsukamoto T, Hamabe Y, Ishida T.

Gan To Kagaku Ryoho. 2009 Jul;36(7):1167-9. Japanese.

PMID:
19620810
3.

[A case of metastatic colorectal cancer with hyperammonemic encephalopathy induced by 5-FU in a patient continuously treated with XELOX therapy].

Nakano E, Kuroki M, Kanno N, Matsumura Y, Miura A, Kikuchi Y, Hirakawa H.

Gan To Kagaku Ryoho. 2013 Dec;40(13):2581-4. Japanese.

PMID:
24335375
4.

[A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].

Teraishi F, Suzuki T, Nakamoto M, Chikuba A, Nezu M, Shimamura H, Watanabe T, Matsuda T, Takiue T, Chikuba H.

Gan To Kagaku Ryoho. 2009 May;36(5):867-9. Japanese.

PMID:
19461197
5.

[A case of metastatic colorectal cancer suffering from hyperammonemic encephalopathy induced by 5-FU, continuously treated with FOLFOX therapy].

Shoji H, Kuroki M, Hiramoto K, Matsumura Y, Miura A, Kikuchi Y, Hirakawa H.

Gan To Kagaku Ryoho. 2010 Aug;37(8):1583-6. Japanese.

PMID:
20716892
6.

The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.

Kikuta S, Asakage T, Nakao K, Sugasawa M, Kubota A.

Auris Nasus Larynx. 2008 Jun;35(2):295-9. Epub 2007 Sep 10.

PMID:
17826933
7.

A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.

Kim BG, Oh SY, Kwon HC, Lee S, Lee DM, Kim SG, Kim DK, Jang JS, Kim MC, Kim SH, Kim HJ.

Am J Clin Oncol. 2010 Jun;33(3):246-50. doi: 10.1097/COC.0b013e3181a650d4.

PMID:
19770628
8.

Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.

Lee NR, Yhim HY, Yim CY, Kwak JY, Song EK.

Ann Pharmacother. 2011 Oct;45(10):e56. doi: 10.1345/aph.1Q038. Epub 2011 Sep 27.

PMID:
21954449
10.

Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study).

Moriwaki T, Bando H, Takashima A, Yamazaki K, Esaki T, Yamashita K, Fukunaga M, Miyake Y, Katsumata K, Kato S, Satoh T, Ozeki M, Baba E, Yoshida S, Boku N, Hyodo I.

Med Oncol. 2012 Dec;29(4):2842-8. doi: 10.1007/s12032-011-0151-2. Epub 2011 Dec 31.

PMID:
22209842
11.

Transient hyperammonemia related to chemotherapy with continuous infusion of high-dose 5-fluorouracil.

Liaw CC, Liaw SJ, Wang CH, Chiu MC, Huang JS.

Anticancer Drugs. 1993 Jun;4(3):311-5.

PMID:
8358058
12.

[FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer].

Yamada I, Ozaka M, Ishii H, Inoue D, Matsuyama M, Takano K, Igarashi M.

Nihon Shokakibyo Gakkai Zasshi. 2014 Nov;111(11):2157-62. Review. Japanese.

PMID:
25373377
13.

[Two cases of hyperammonemic patients treated by chemotherapy for colorectal cancer].

Aihara A, Terasawa M, Furukawa S, Kasai R, Ito T, Ochiai T, Kumagai Y, Iida M, Yamazaki S.

Gan To Kagaku Ryoho. 2012 May;39(5):839-42. Review. Japanese.

PMID:
22584345
14.

[A clinical case of recurrent small intestinal cancer successfully treated with FOLFOX6].

Fukunaga H, Endo W, Ota H, Yoshioka S, Hojo S, Fujie Y, Yoshioka A, Toyoda Y, Shimizu K, Maeura Y.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1972-4. Japanese.

PMID:
23267947
15.

[A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].

Ishikawa T, Nakamura M, Ohkuma K, Hisano C, Nakano S, Maruyama T, Kaji Y, Niho Y, Masumoto N.

Gan To Kagaku Ryoho. 2000 Aug;27(9):1443-7. Japanese.

PMID:
10969604
16.

[Second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer after resection of the primary lesion].

Abe H, Mafune K, Minamimura K, Abe M, Umemura A, Hirata T.

Gan To Kagaku Ryoho. 2013 May;40(5):601-4. Japanese.

PMID:
23863581
17.

Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).

Weissinger F, Reymond M, Dumke K, Kr├╝ger M.

Onkologie. 2011;34(10):548-51. doi: 10.1159/000332226. Epub 2011 Sep 19.

PMID:
21985855
18.

[A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective].

Suzuki N, Suzuki S, Tominaga K, Hoshino M, Naruse H, Fukushima M, Murakami M.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2267-9. Japanese.

PMID:
23268045
19.
20.

[Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].

Tagami Y, Ogata S, Katakawa M, Bando Y.

Gan To Kagaku Ryoho. 2012 Feb;39(2):317-9. Japanese.

PMID:
22333652
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk